Eledon Pharmaceuticals, Inc.
ELDN
$2.62
$0.0451.75%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 28.66% | 191.36% | 174.31% | 31.17% | 17.14% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -9.70% | -60.07% | 29.13% | -12.64% | 72.18% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -93.63% | 1.85% | 710.00% | 391.11% | -34.03% |
| Total Current Assets | 27.73% | 166.21% | 156.07% | 29.40% | 18.47% |
|
|
|||||
| Total Current Assets | 27.73% | 166.21% | 156.07% | 29.40% | 18.47% |
| Net Property, Plant & Equipment | 24.48% | 214.81% | 153.70% | 2.61% | 12.30% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 35.69% | 91.35% | 95.16% | -9.87% | 13.84% |
| Total Assets | 20.27% | 99.59% | 99.18% | 19.26% | 12.83% |
|
|
|||||
| Total Accounts Payable | 171.46% | 55.63% | 503.21% | 1,160.22% | -2.23% |
| Total Accrued Expenses | 109.31% | 183.90% | 113.36% | 216.14% | 55.99% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 24.91% | 14.44% | -18.02% | -53.03% | -31.03% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 127.70% | 116.27% | 197.23% | 330.80% | 22.96% |
|
|
|||||
| Total Current Liabilities | 127.70% | 116.27% | 197.23% | 330.80% | 22.96% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 20.98% | -- | -- | 279.52% | 109.78% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -79.85% | -59.49% | -39.65% | 1,367.69% | 6,896.18% |
| Total Liabilities | -69.86% | -51.09% | -27.60% | 713.65% | 1,786.83% |
|
|
|||||
| Common Stock & APIC | 11.66% | 45.19% | 45.04% | 19.09% | 17.41% |
| Retained Earnings | 3.77% | -5.55% | -11.33% | -33.14% | -73.80% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 692.10% | 877.97% | 1,539.01% | -16.73% | -108.51% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 692.10% | 877.97% | 1,539.01% | -16.73% | -108.51% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1,347.24% | 877.97% | 1,539.01% | -16.73% | -108.51% |
|
|
|||||